Skip to main content

Table 2 Immunological and treatment parameters at the initiation of therapy

From: Outcome of highly active antiretroviral therapy in HIV- infected Indian children

Parameter Values
Duration of follow up while on HAART, months, median (IQR) 43 (17,68)
CD4 count, cells/μL, median (IQR) 340 (185,704)
 Age <2 years (n = 27) 424 (304,729)
 Age 2-5years (n = 20) 460 (260,871)
 Age >5 years (n = 128) 288 (163,639)
CD4%, mean (SD) 13.3 (10.7)
Baseline regime of HAART, n (%)  
 d4T+3TC+NVP 141 (80.6)
 d4T+3TC+EFV 19 (10.8)
 AZT+3TC+NVP 11 (6.3)
 AZT+3TC+EFV 4 (2.3)
  1. IQR: interquartile range.
  2. HIV: human immunodeficiency virus, HAART: highly active anti-retroviral therapy.
  3. d4T: stavudine, 3TC: lamivudine, AZT: zidovudine, NVP: nevirapine, EFV: efavirenz.